Consensus statement. Corticosteroid therapy in ENT in the context of the COVID-19 pandemic - 28/08/20
, C. Vincent b, C. Parietti Winkler c, N. Loundon d, V. Couloigner d, F. Tankere e, S. Tringali f, P. Gallet c, J.-F. Papon g, M. Montava h, J.-P. Lavieille h, A. Charpiot i, S. Schmerber j
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Abstract |
This consensus statement about the indications and modalities of corticosteroid treatment in the context of the COVID-19 pandemic was jointly written by experts from the French Association of Otology and Oto-Neurology (AFON) and from the French Society of Otorhinolaryngology, Head and Neck Surgery (SFORL). There is currently not enough data in favour of danger or benefit from corticosteroids in COVID-19, so until this matter is resolved it is advisable to limit their indications to the most serious clinical pictures for which it is well established that this type of treatment has a positive impact on the progression of symptoms. In Grade V and VI Bell's palsy according to the House-Brackmann grading system, a week's course of oral corticosteroids is recommended. Corticosteroid therapy is also recommended in cases of sudden hearing loss of more than 60dB, either in the form of intratympanic injections or a week's course of oral medication. In rhinology, there is no indication for systemic corticosteroid therapy in the current situation. However, patients are advised to continue with their local corticosteroid therapy in the form of a nasal spray or by inhalation. Treatments with corticosteroid nasal sprays can still be prescribed if there is no alternative. Finally, systemic or local corticosteroid therapy is not indicated for bacterial ENT infections.
El texto completo de este artículo está disponible en PDF.Keywords : COVID-19, SARS-CoV-2, Anosmia, Prednisone, Bell's palsy, Sudden hearing loss
Esquema
Vol 137 - N° 4
P. 315-317 - septembre 2020 Regresar al número
Artículo precedente
- COVID-19 and rhinology, from the consultation room to the operating theatre
- T. Radulesco, B. Verillaud, E. Béquignon, J.-F. Papon, R. Jankowski, L. Le Taillandier De Gabory, P. Dessi, A. Coste, E. Serrano, S. Vergez, F. Simon, V. Couloigner, C. Rumeau, J. Michel, French Association of Rhinology (AFR), French Society of Otorhinolaryngology, Head and Neck Surgery (SFORL)
- Treatment of sleep apnea by ENT specialists during the COVID-19 pandemic
- P.-L. Bastier, N. Aisenberg, F. Durand, P. Lestang, D. Abedipour, O. Gallet de Santerre, V. Couloigner, E. Bequignon
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.